EUVIMEDEUVIMED entdecken
Crossref

Application of CRISPR-Based Human and Bacterial Ribosomal RNA Depletion for SARS-CoV-2 Shotgun Metagenomic Sequencing

Stacey Cerón, Nathan C Clemons, Benjamin von Bredow, Shangxin Yang iD

American Journal of Clinical Pathology · 01.02.2023 · 159 (2) · 111-115

DOI: 10.1093/ajcp/aqac135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Clinical Pathology, online erschienen am 10.12.2022. Verfasst von Stacey Cerón und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA, USA. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The aim of this study is to evaluate the effectiveness of a CRISPR-based human and bacterial ribosomal RNA (rRNA) depletion kit (JUMPCODE Genomics) on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) shotgun metagenomic sequencing in weakly positive respiratory samples.

Methods

Shotgun metagenomics was performed on 40 respiratory specimens collected from solid organ transplant patients and deceased intensive care unit patients at UCLA Medical Center in late 2020 to early 2021. Human and bacterial rRNA depletion was performed on remnant library pools prior to sequencing by Illumina MiSeq. Data quality was analyzed using Geneious Prime, whereas the identification of SARS-CoV-2 variants and lineages was determined by Pangolin.

Results

The average genome coverage of the rRNA-depleted respiratory specimens increased from 72.55% to 93.71% in overall samples and from 29.3% to 83.3% in 15 samples that failed to achieve sufficient genome coverage using the standard method. Moreover, rRNA depletion enhanced genome coverage to over 85% in 11 (73.3%) of 15 low viral load samples with cycle threshold values up to 35, resulting in the identification of genotypes.

Conclusion

The CRISPR-based human and bacterial rRNA depletion enhanced the sensitivity of SARS-CoV-2 shotgun metagenomic sequencing, especially in low viral load samples.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19HumansRNA, RibosomalMetagenomics

Stichwörter der Autor:innen

COVID-19Genomic surveillanceSARS-CoV-2SequencingShotgun metagenomics

Substanzen

RNA, Ribosomal

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA, USA.

ORCID-Profile: Shangxin Yang

Zitieren

APA

Cerón, S., Clemons, N. C., von Bredow, B., & Yang, S. (2023). Application of CRISPR-Based Human and Bacterial Ribosomal RNA Depletion for SARS-CoV-2 Shotgun Metagenomic Sequencing. American Journal of Clinical Pathology, 159(2), 111-115. https://doi.org/10.1093/ajcp/aqac135

Vancouver

Cerón S, Clemons NC, von Bredow B, Yang S. Application of CRISPR-Based Human and Bacterial Ribosomal RNA Depletion for SARS-CoV-2 Shotgun Metagenomic Sequencing. American Journal of Clinical Pathology. 2023;159(2):111-115. doi:10.1093/ajcp/aqac135

BibTeX
@article{Cern2023,
  author = {Cerón, Stacey and Clemons, Nathan C and von Bredow, Benjamin and Yang, Shangxin},
  title = {Application of CRISPR-Based Human and Bacterial Ribosomal RNA Depletion for SARS-CoV-2 Shotgun Metagenomic Sequencing},
  journal = {American Journal of Clinical Pathology},
  year = {2023},
  volume = {159},
  number = {2},
  pages = {111--115},
  doi = {10.1093/ajcp/aqac135}
}
Kostenlos starten →